Galapagos UK’s Michael Smyth on RNA-based tech: the pharmaphorum podcastEpisode 35 of the pharmaphorum podcast hears from Michael Smyth about Galapagos UK and joining the company as Share XGalapagos UK’s Michael Smyth on RNA-based tech: the pharmaphorum podcasthttps://pharmaphorum.com/podcast/galapago-uk-michael-smyth-rna/
COVID-19’s lasting impact on digital communication in healthcareThe ongoing digital transformation of the healthcare and pharmaceutical industries has been greatly accelerated during the coronavirus pandemic. Share XCOVID-19’s lasting impact on digital communication in healthcarehttps://pharmaphorum.com/whitepapers/covid-19s-lasting-impact-on-digital-communication-in-healthcare/
Coronavirus pharma news roundup – 31/07/20Vaccines, AI-driven drug discovery and llamas all hit the headlines this week as the search for a way Share XCoronavirus pharma news roundup – 31/07/20https://pharmaphorum.com/views-and-analysis/coronavirus-pharma-news-roundup-31-07-20/
Preparing for the next decade of innovation in immuno-oncologyImmuno-oncology has seen some striking clinical advances in the 10 years since the approval of the first therapeutic Share XPreparing for the next decade of innovation in immuno-oncologyhttps://pharmaphorum.com/oncology/immuno-oncology-clinicial-trial-market-access/
Livestream of digital health event Fight The PandemicThe global health ecosystem’s unified effort in fighting the unparalleled challenge presented by COVID-19 will be the subject Share XLivestream of digital health event Fight The Pandemichttps://pharmaphorum.com/views-and-analysis/digital-health-innovation-covid-event/
Homeschooling resources during coronavirus working-from-homeWith schools closed and many pharma and healthcare companies asking employees to work from home during the coronavirus Share XHomeschooling resources during coronavirus working-from-homehttps://pharmaphorum.com/views-analysis-sales-marketing/homeschooling-resources-coronavirus-covid19-working-home/
AI for rare diseases: putting tech to work for small populationsWith the 12th annual Rare Disease Day on the horizon, it’s a pertinent time to think about how Share XAI for rare diseases: putting tech to work for small populationshttps://pharmaphorum.com/spotlight/ai-in-pharma-marketing/ai-rare-diseases/
Nine for 2019: how did we do on our predictions, and what does this mean for 2020?Year-ends prompt reflection, both on what’s happened in the last 12 months and on the year ahead. At Share XNine for 2019: how did we do on our predictions, and what does this mean for 2020?https://pharmaphorum.com/views-and-analysis/nine-for-2019-2020/
Leading from the front in cell therapyIn these videos, senior stakeholders from Kite, a Gilead Company, describe how a culture of innovation and partnership Share XLeading from the front in cell therapyhttps://pharmaphorum.com/video/leading-from-the-front-in-cell-therapy/
